Dice Alpha Inc. has synthesized phenyl acetamide compounds acting as interleukin-17A (IL-17A) production inhibitors reported to be useful for the treatment of psoriasis, radiographic axial spondyloarthritis (ankylosing spondylitis), hidradenitis suppurativa, spondyloarthritis, psoriatic and rheumatoid arthritis.